FDA inspection
Hammersmith Medicines Research: FDA inspection ending Nov 22, 2019
FDA inspection 1116497 · No Action Indicated (NAI) · London
Key facts
| Inspection ID | 1116497 |
|---|---|
| Firm | Hammersmith Medicines Research |
| FEI number | 3003446696 |
| Address | 44 Cumberland Avenue |
| City | London |
| Country | United Kingdom |
| Fiscal year | 2020 |
| Inspection end date | Nov 22, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data